DAWN PALETTA: Open Payments
NPI 1902856115 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,143 in 130 payments from 22 companies in 2025. Trend: 2023 $1,913 · 2024 $4,117 · 2025 $3,143
Food & beverage: $3,088Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $437 |
| PFIZER INC. | 14 | $422 |
| Lilly USA, LLC | 10 | $302 |
| GENZYME CORPORATION | 8 | $249 |
| Amgen Inc. | 8 | $234 |
| Regeneron Healthcare Solutions, Inc. | 9 | $222 |
| Galderma Laboratories, L.P. | 9 | $212 |
| Organon LLC | 5 | $184 |
| UCB, Inc. | 13 | $145 |
| Novartis Pharmaceuticals Corporation | 5 | $111 |
Products named: DUPIXENT, CIBINQO, EBGLYSS, RINVOQ, OTEZLA, VTAMA, SKYRIZI, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
